Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPV 6 virus-like particle vaccine for recurrent respiratory papillomatosis
ACTRN12607000016437Phase 2Not yet recruiting
- Sponsor
- The University of Queensland
- Start
- Nov 2006
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of human papillomavirus type 6 virus-like particle vaccine in Laryngeal papilloma (RRP) (3 arms), sponsored by The University of Queensland. Primary endpoints: Immune response to investigational vaccine and Safety and tolerability at three dose levels. Planned start Nov 2006; status: not yet recruiting.
02
Drugs
human papillomavirus type 6 virus-like particle vaccine
03
Conditions
Laryngeal papilloma (RRP)
Beyond the preview
Go deeper on ACTRN12607000016437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000016437.